{"organizations": [], "uuid": "4f6da2cd4e15d6cb7252c1e072069ce6b611cca2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-clovis-oncology-says-sec-issued-we/brief-clovis-oncology-says-sec-issued-wells-notices-to-co-certain-of-its-officers-idUSFWN1RN0MZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Clovis Oncology Says SEC Issued 'Wells Notices' To Co & Certain Of Its Officers", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T16:35:00.000+03:00", "replies_count": 0, "uuid": "4f6da2cd4e15d6cb7252c1e072069ce6b611cca2"}, "author": "", "url": "https://www.reuters.com/article/brief-clovis-oncology-says-sec-issued-we/brief-clovis-oncology-says-sec-issued-wells-notices-to-co-certain-of-its-officers-idUSFWN1RN0MZ", "ord_in_thread": 0, "title": "BRIEF-Clovis Oncology Says SEC Issued 'Wells Notices' To Co & Certain Of Its Officers", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "wells notices", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "clovis oncology inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 10, 2018 / 1:37 PM / in 5 minutes BRIEF-Clovis Oncology Says SEC Issued 'Wells Notices' To Co & Certain Of Its Officers Reuters Staff 1 Min Read \nApril 10 (Reuters) - Clovis Oncology Inc: \n* CLOVIS ONCOLOGY SAYS ON APRIL 9 SEC ISSUED ‘WELLS NOTICES’ TO CO & CERTAIN OF ITS CURRENT AND FORMER OFFICERS - SEC FILING \n* SEC’S ‘WELLS NOTICES’ ALLEGES VIOLATIONS OF SOME PROVISIONS OF SECURITIES ACT OF 1933 AND SECURITIES EXCHANGE ACT OF 1934 \n* ALLEGED VIOLATIONS RELATE TO CO'S REGULATORY UPDATE IN NOV 2015 THAT FDA REQUESTED MORE CLINICAL DATA ON EFFICACY, SAFETY OF ROCILETINIB Source text: ( bit.ly/2IDAEmj ) Further company coverage:", "external_links": [], "published": "2018-04-10T16:35:00.000+03:00", "crawled": "2018-04-10T16:47:46.002+03:00", "highlightTitle": ""}